About Intrinsic Therapeutics
Intrinsic Therapeutics is a private company based in Woburn, Massachusetts. It has reported $219,487,001 raised in nine offerings on Form D since February 2010. Its chief executive is Cary Hagan.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Nov 30, 2023 | Dec 8, 2023 | $55,489,287of $68.4M target | 9 | $6.1M | EquityRule 506(b) | Form D ↗ |
| Jul 14, 2023 | Aug 18, 2023 | $5,501,901fully sold | 18 | $305K | EquityRule 506(b) | Form D ↗ |
| Mar 29, 2023 | Apr 13, 2023 | $5,914,800of $7.5M target | 9 | $657K | EquityRule 506(b) | Form D ↗ |
| Mar 30, 2021 | Apr 7, 2021 | $38,444,385of $40.0M target | 13 | $2.9M | EquityRule 506(b) | Form D ↗ |
| Apr 8, 2019 | Apr 23, 2019 | $38,785,331of $41.6M target | 28 | $1.3M | EquityRule 506(b) | Form D ↗ |
| Dec 1, 2016 | Dec 16, 2016amended Mar 21, 2017 | $28,432,510fully sold | 22 | $1.2M | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Aug 22, 2014 | Sep 17, 2014 | $17,256,239of $20.8M target | 28 | $616K | EquityRule 506(b) | Form D ↗ |
| Oct 26, 2012 | Nov 8, 2012 | $11,662,297of $12.2M target | 11 | $1.0M | Equity, Securities on exercise06 | Form D ↗ |
| Feb 12, 2010 | Feb 25, 2010 | $18,000,251of $20.0M target | 11 | $1.6M | Equity, Options06 | Form D ↗ |
| Total, nine offerings | $219,487,001 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Intrinsic Therapeutics's Form D filed Dec 8, 2023.
Earlier filings also listed Kevin Sidow (director, last listed Aug 2023), Jeani Delagardelle (director, last listed Aug 2023), Joshua Makower (director, last listed Apr 2021), Carey Hagan (president and chief executive officer, director, last listed Apr 2021), Kevin Connors (director, last listed Apr 2019) and William Tidmore (director, last listed Nov 2012).